Login
No login? Register now to unlock hella tokens
No login? Register now to unlock hella tokens
Log In person
MiMedx Group Inc logo
MiMedx Group Inc MDXG
summarize 1 total product line
calendar_month Revenue as of 12/31/2023
Reporting Segmentarrow_drop_up Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Wound & Surgical
Biologically-Derived Tissue Scaffolding Products; private insurance
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.
321.48M 100.00%
keyboard_arrow_right keyboard_arrow_down
Wound & Surgical
Biologically-Derived Tissue Scaffolding Products; private insurance
321.48M 100.00%
keyboard_arrow_right
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.